Eligi
Med
Ensayos clinicos
Suscripcion
Sobre EligiMed
Ensayos Clinicos | EligiMed
Ensayos clinicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
Radium-223 Alpha Emitter Agent in Non-intervention Safety Study in mCRPC popUlation for Long-teRm Evaluation
OBSERVATIONAL
Inicio: 20 de ago de 2014
ID: NCT02141438
Completado
Fase 4
ClinicalTrials.gov
SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects With Asthma
INTERVENTIONAL
Inicio: 18 de nov de 2011
ID: NCT01475721
Por invitacion
ClinicalTrials.gov
Use of Machine Learning Techniques for Serial Assessment of Systemic Inflammatory Markers in Breast Cancer Patients
OBSERVATIONAL
Inicio: 1 de ago de 2024
ID: NCT06447532
Aun no recluta
ClinicalTrials.gov
The Amper Study: Amniotic Membrane for the Prevention of Mesh Exposure in Vaginal Reconstructive Surgery
INTERVENTIONAL
Inicio: 1 de mar de 2026
ID: NCT07414849
Reclutando
Fase 2
ClinicalTrials.gov
A Randomized Phase II, Double-blind, Multicenter Study Evaluating the Efficacy and Safety of Autogene Cevumeran Plus Nivolumab Versus Nivolumab as Adjuvant Therapy in Patients With High-risk Muscle-invasive Urothelial Carcinoma
INTERVENTIONAL
Inicio: 9 de dic de 2024
ID: NCT06534983
Activo, no recluta
Fase 3
ClinicalTrials.gov
An Open-Label Extension Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients With Severe Hypertriglyceridemia (SHTG)
INTERVENTIONAL
Inicio: 13 de dic de 2022
ID: NCT05681351
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) + Lenvatinib (E7080/MK-7902) + Chemotherapy Compared With Standard of Care as First-line Intervention in Participants With Metastatic Esophageal Carcinoma
INTERVENTIONAL
Inicio: 28 de jul de 2021
ID: NCT04949256
Completado
Fase 2
ClinicalTrials.gov
A Double-blind, Placebo-controlled, Randomised, Parallel-group, Phase II, Multi-centre Study to Assess the Efficacy, Safety and Tolerability of 4 Twice Daily Doses and 2 Once Daily Doses of AZD1981 Given as Tablets During 12 Weeks in Asthmatic Patients
INTERVENTIONAL
Inicio: 1 de oct de 2010
ID: NCT01197794
Completado
Fase 3
ClinicalTrials.gov
A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE).
INTERVENTIONAL
Inicio: 1 de dic de 2009
ID: NCT01000727
Reclutando
Fase 3
ClinicalTrials.gov
A Phase IIIB, Long-Term Follow-Up of CAB LA for Participants in HPTN 083 and HPTN 084 CAB PrEP Studies at Risk of HIV Acquisition
INTERVENTIONAL
Inicio: 14 de may de 2024
ID: NCT06134362
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of MK-7240 in Participants With Moderately to Severely Active Ulcerative Colitis
INTERVENTIONAL
Inicio: 25 de oct de 2023
ID: NCT06052059
Terminado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis
INTERVENTIONAL
Inicio: 19 de oct de 2021
ID: NCT04963270
Completado
Fase 3
ClinicalTrials.gov
BAX 326 (Recombinant Factor IX): Evaluation of Safety, Immunogenicity, and Hemostatic Efficacy in Previously Treated Patients With Severe (FIX Level < 1%) or Moderately Severe (FIX Level <= 2%) Hemophilia B - A Continuation Study
INTERVENTIONAL
Inicio: 12 de abr de 2011
ID: NCT01286779
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 2)
INTERVENTIONAL
Inicio: 21 de jul de 2025
ID: NCT06976203
Completado
Fase 2
ClinicalTrials.gov
A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Assess Efficacy and Safety of Atuliflapon Given Orally Once Daily for Twelve Weeks in Adults With Moderate to Severe Uncontrolled Asthma
INTERVENTIONAL
Inicio: 27 de ene de 2022
ID: NCT05251259
Terminado
Fase 2
ClinicalTrials.gov
A Phase IIb Randomized, Controlled, Partially Blinded Clinical Trial to Investigate Safety, Efficacy and Dose-response of BMS-986001 in Treatment-naive HIV-1-infected Subjects, Followed by an Open-label Period on the Recommended Dose
INTERVENTIONAL
Inicio: 1 de feb de 2011
ID: NCT01489046
Completado
Fase 4
ClinicalTrials.gov
A 26 Week Randomised, Multinational, Open Labelled, 2 Armed, Parallel Group, Treat-to-target Once Daily Treatment Trial With Insulin Detemir Versus Insulin Glargine, Both in Combination With Metformin in Subjects With Type 2 Diabetes
INTERVENTIONAL
Inicio: 1 de may de 2009
ID: NCT00909480
Completado
Fase 2
ClinicalTrials.gov
A Phase II Study of Dasatinib Therapy in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia or With Ph+ Leukemias Resistant or Intolerant to Imatinib
INTERVENTIONAL
Inicio: 20 de mar de 2009
ID: NCT00777036
Por invitacion
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Dose-Blind, Phase 3 Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of Litifilimab (BIIB059) in Adult Participants With Active Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 10 de jun de 2022
ID: NCT05352919
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of BMS-298585 in Combination With Glyburide Therapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Sulfonylurea Therapy Alone
INTERVENTIONAL
Inicio: 1 de jul de 2003
ID: NCT00162175
Anterior
1
...
390
391
392
...
434
Siguiente
Filtros